BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 24096181)

  • 1. Risk factors for unscheduled delivery in patients with placenta accreta.
    Bowman ZS; Manuck TA; Eller AG; Simons M; Silver RM
    Am J Obstet Gynecol; 2014 Mar; 210(3):241.e1-6. PubMed ID: 24096181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of unscheduled delivery in women with placenta accreta according to planned gestational age at delivery.
    Saccone G; Migliorini S; Crocetto F; Della Corte L; Cancellieri E; Improda L; Improda FP; Maruotti GM; Cancelmo G; Imbimbo C; Bifulco G; Zullo F; Berghella V
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):5308-5311. PubMed ID: 33504230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient selection for later delivery timing with suspected previa-accreta.
    Perlman NC; Little SE; Thomas A; Cantonwine DE; Carusi DA
    Acta Obstet Gynecol Scand; 2017 Aug; 96(8):1021-1028. PubMed ID: 28374887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of placenta accreta spectrum at vaginal birth after cesarean delivery.
    Matsuzaki S; Rau AR; Mandelbaum RS; Tavakoli A; Mazza GR; Ouzounian JG; Matsuo K
    Am J Obstet Gynecol MFM; 2023 Oct; 5(10):101115. PubMed ID: 37543142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between emergent and elective delivery in women with placenta accreta.
    Pri-Paz S; Fuchs KM; Gaddipati S; Lu YS; Wright JD; Devine PC
    J Matern Fetal Neonatal Med; 2013 Jul; 26(10):1007-11. PubMed ID: 23339591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal and neonatal outcomes among scheduled versus unscheduled deliveries in women with prenatally diagnosed, pathologically proven placenta accreta.
    Pettit KE; Stephenson ML; Truong YN; Henry D; Murphy A; Kim L; Field N; Wing DA; Ramos GA;
    J Matern Fetal Neonatal Med; 2019 Mar; 32(6):927-931. PubMed ID: 29103344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unsuspected placenta accreta spectrum at vaginal delivery: assessment of incidence, characteristics, and maternal morbidity.
    Rau AR; Youssefzadeh AC; Matsuzaki S; Mandelbaum RS; Ouzounian JG; Matsuo K
    Am J Obstet Gynecol MFM; 2023 May; 5(5):100805. PubMed ID: 36774226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interpregnancy interval as a risk factor for placenta accreta.
    Wax JR; Seiler A; Horowitz S; Ingardia CJ
    Conn Med; 2000 Nov; 64(11):659-61. PubMed ID: 11125633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The maternal outcome in placenta accreta: the significance of antenatal diagnosis and non-separation of placenta at delivery.
    Wong HS; Hutton J; Zuccollo J; Tait J; Pringle KC
    N Z Med J; 2008 Jul; 121(1277):30-8. PubMed ID: 18677328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placenta accreta and vaginal bleeding according to gestational age at delivery.
    Rac MWF; Wells CE; Twickler DM; Moschos E; McIntire DD; Dashe JS
    Obstet Gynecol; 2015 Apr; 125(4):808-813. PubMed ID: 25751201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for placenta accreta: a large prospective cohort.
    Bowman ZS; Eller AG; Bardsley TR; Greene T; Varner MW; Silver RM
    Am J Perinatol; 2014 Oct; 31(9):799-804. PubMed ID: 24338130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of prospectively-collected consecutive cases of antenatal-suspected placenta accreta.
    Weiniger CF; Einav S; Deutsch L; Ginosar Y; Ezra Y; Eid L
    Int J Obstet Anesth; 2013 Nov; 22(4):273-9. PubMed ID: 23932233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Committee opinion no. 529: placenta accreta.
    Committee on Obstetric Practice
    Obstet Gynecol; 2012 Jul; 120(1):207-11. PubMed ID: 22914422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for emergent preterm delivery in women with placenta previa and ultrasound findings suspicious for placenta accreta.
    Fishman SG; Chasen ST
    J Perinat Med; 2011 Nov; 39(6):693-6. PubMed ID: 21801091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between Antenatal Vaginal Bleeding and Adverse Perinatal Outcomes in Placenta Accreta Spectrum.
    Mulhall JC; Ireland KE; Byrne JJ; Ramsey PS; McCann GA; Munoz JL
    Medicina (Kaunas); 2024 Apr; 60(4):. PubMed ID: 38674323
    [No Abstract]   [Full Text] [Related]  

  • 16. Maternal and neonatal outcomes in planned versus emergency cesarean delivery for placenta accreta spectrum: A multinational database study.
    Morlando M; Schwickert A; Stefanovic V; Gziri MM; Pateisky P; Chalubinski KM; Nonnenmacher A; Morel O; Braun T; Bertholdt C; Van Beekhuizen HJ; Collins SL;
    Acta Obstet Gynecol Scand; 2021 Mar; 100 Suppl 1():41-49. PubMed ID: 33713033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perinatal outcomes in women with preterm rupture of membranes between 24 and 32 weeks of gestation and a history of vaginal bleeding.
    Hnat MD; Mercer BM; Thurnau G; Goldenberg R; Thom EA; Meis PJ; Moawad AH; Iams JD; Van Dorsten JP;
    Am J Obstet Gynecol; 2005 Jul; 193(1):164-8. PubMed ID: 16021074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cryopreserved embryo transfer is an independent risk factor for placenta accreta.
    Kaser DJ; Melamed A; Bormann CL; Myers DE; Missmer SA; Walsh BW; Racowsky C; Carusi DA
    Fertil Steril; 2015 May; 103(5):1176-84.e2. PubMed ID: 25747133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antepartum vaginal bleeding: characteristics associated with delivery within seven days.
    Newman RA; Makhoul J; Chang J; Senderoff D; Bosse B; Crosland BA; Seet E; Chan K
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):8580-8585. PubMed ID: 34645356
    [No Abstract]   [Full Text] [Related]  

  • 20. Society for Maternal-Fetal Medicine (SMFM) Consult Series #44: Management of bleeding in the late preterm period.
    ; Gyamfi-Bannerman C
    Am J Obstet Gynecol; 2018 Jan; 218(1):B2-B8. PubMed ID: 29079144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.